Using stem cells to treat various chronic and acute health conditions

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multi-arm, multi-site study evaluates the safety, tolerability, and efficacy of stem cell therapy for a range of acute and chronic conditions, including autoimmune diseases, cardiovascular disorders, and diabetes complications. The study is designed to gather clinical outcomes using various validated instruments that assess both general quality of life and condition-specific metrics. Participants will receive treatments with PrimePro™ or PrimeMSK™ stem cell therapies, with follow-up visits to monitor their progress and response to treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age 18 and older
* Ability to provide informed consent
* Availability for follow up visits

Exclusion Criteria:

* Active or recent malignancy (within last 2 years)
* Pregnancy or breast-feeding
* Inability to provide informed consent

Where it's running

• Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites
  Culver City, California, United States Recruiting

Study contacts

• Principal investigator: Ernst R Von Schwarz, MD, PhD — HeartStem Institute, Southern California Hospital at Culver City
• Study coordinator: Paul C Bogaardt, PhD(c), MSc, MBA
• Email: paul@thomasadvancedmedical.com
• Phone: 866 864 7789

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Noninvasive spinal cord stimulation for recovery after spinal cord injury

  This study is testing a new non-invasive treatment to see if it can help improve bladder, bowel, sexual, and heart functions in people who have had a spinal cord injury for a few months.

  Recruiting University of British Columbia · Vancouver, British Columbia · NCT06587841

• PRP injection for female sexual function

  This trial tests whether a patient’s own PRP injection into the front vaginal wall can improve sexual function in women with sexual dysfunction.

  Recruiting Icahn School of Medicine at Mount Sinai · New York, New York · NCT07920900

• ETHY-001 safety and activity in Thyroid Eye Disease (TED)

  This study tests ETHY-001 versus placebo to see if it is safe, tolerable, and shows activity in people with thyroid eye disease.

  Recruiting at 2 sites Phase 1 Ethyreal Bio, Inc. · Orland Park, Illinois and 2 other locations · NCT07885605

• Measuring bottom-of-foot pressures in people with lateral forefoot amputation due to diabetes

  Aiming to see if people with lateral forefoot amputation due to diabetes have higher pressures under remaining foot areas while walking.

  Recruiting at 2 sites Nanyang Technological University · Singapore and 1 other locations · NCT07865208

• What predicts religious orientation attitudes in menopausal women

  This study tests whether how severe menopausal symptoms and beliefs about sexual myths relate to intrinsic religious orientation in healthy women going through menopause.

  Recruiting KTO Karatay University · Konya · NCT07797296

• Sexual function and quality of life in monogamous vs polygamous marriages among Egyptian men

  This is a web-based survey to see if marital structure affects erectile function and sexual quality of life in Egyptian men who are married.

  Recruiting Al-Azhar University · Cairo · NCT07783958

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.